RecruitingNCT06421415

Long Term Effect of AIT in Children

Sponsor

Odense University Hospital

Enrollment

100 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Allergy in Children

Summary

The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.

Eligibility

Min Age: 4 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Allergen Immunotherapy Extract for people with allergy in children. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 4 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAllergen Immunotherapy Extract

Patients will be treated as usual. The study is an observation of the long term effect of the treatment

Locations(2)

Hans Christian Andersen Children's Hospital

Odense, Odense C, Denmark

Hans Christian Andersen Children's Hospital

Odense, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06421415

Related Trials

Steroid Use in Treatment of Allergic Reactions to Food

NCT073417762 locations

Allergen Provocations- HCA Children's Hospital

NCT043315221 location